US FDA Approves Two New HIV Medications

The US FDA has approved two new HIV oral drugs to treat adults, doravirine and the combination tablet (doravirine/lamivudine/tenofovir disoproxil fumarate). The latter was approved with a boxed warning to "flag risk of worsening hepatitis B infection."